Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

NCT04536532 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

52

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision to discontinue trial

Conditions

Hepatitis B, Chronic

Interventions

DRUG: HEC121120 tablets
DRUG: HEC121120 placebo tablets
DRUG: entecavir tablets
DRUG: entecavir placebo tablets

Sponsor

Sunshine Lake Pharma Co., Ltd.